A comparative study of the effect of vaginal and pessary progesterone along with the vaginal progesterone in preventing preterm delivery in twin pregnancies of pregnant women
Comparison of the effect of vaginal progesterone and pessary on preventing preterm labor in twin pregnancies.
Design
TThe primary ultrasound of pregnant women is performed by the research perinatologist to check and determine the length of the cervix. And it is referred to the associate perinatologist for the administration of progesterone and pessary implantation according to the study group. The main researcher examines the final outcome of pregnant women and finally the data analyst performs the data analysis without knowing the type of intervention. It should be noted that the pessary is removed by the main researcher or collaborator of the project during labor pains or gestational age over 37 weeks or cesarean section.
Settings and conduct
This is a double blind randomized clinical trial study which women pregnant with twins referred to Hazrat Rasool Akram Hospitals in 1403-1404 according to inclusion criteria will be included to the study. Women with a cervical length less than 25 mm will be randomly divided using a random number table into two groups.
Participants/Inclusion and exclusion criteria
In this study women pregnant with twins, with gestational age of 16-18 weeks and cervical length less than 25 mm will be enrolled to the study.
Exclusion criteria will be included: Twin-Twin transfusion syndrome, monoamniotic twins, rupture of the membranes, the presence of a major or chromosomal abnormality in at least one fetus, women who have cervical cerclage in their current pregnancy, placenta previa
Intervention groups
In intervention group, pregnant women will be treated with vaginal progesterone (cyclogest 200 mg/daily) and pessary and in n control will be only treated with vaginal progesterone (cyclogest 200 mg/daily).
Main outcome variables
The primary outcome of this study is gestational age at the delivery time.
General information
Reason for update
Acronym
IRCT registration information
IRCT registration number:IRCT20151207025420N2
Registration date:2024-08-03, 1403/05/13
Registration timing:registered_while_recruiting
Last update:2024-08-03, 1403/05/13
Update count:0
Registration date
2024-08-03, 1403/05/13
Registrant information
Name
Neda Hashemi
Name of organization / entity
Iran University of Medical Science
Country
Iran (Islamic Republic of)
Phone
+98 21 6435 2562
Email address
hashemi.n@iums.ac.ir
Recruitment status
recruiting
Funding source
Expected recruitment start date
2024-07-22, 1403/05/01
Expected recruitment end date
2025-07-23, 1404/05/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
A comparative study of the effect of vaginal and pessary progesterone along with the vaginal progesterone in preventing preterm delivery in twin pregnancies of pregnant women
Public title
A comparative study of the effect of vaginal and pessary progesterone along with the vaginal progesterone in preventing preterm delivery in twin pregnancies of pregnant women
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Twin pregnancies
Pregnancy age 16-18 weeks
The cervical length less than 25 mm
Exclusion criteria:
Twin-Twin Transfusion Syndrome
monoamniotic twins
Rupture of the membranes
The presence of a major or chromosomal abnormality in at least one fetus
Women who have cervical cerclage in their current pregnancy
Placenta Previa
Progesterone treatment before inclusion
Progesterone sensitivity
Severe liver defect
Porphyria
Otosclerosis
Major depression
Taking drugs that interfere with the effect of progesterone
Age
From 18 years old to 45 years old
Gender
Female
Phase
4
Groups that have been masked
Investigator
Data analyser
Sample size
Target sample size:
100
Randomization (investigator's opinion)
Randomized
Randomization description
In this study, with a sample size of 100 people, 50 balls for the vaginal progesterone intervention group and 50 balls for the vaginal and pessary progesterone group are placed in a lottery container, and then the balls are randomly removed from the container without replacement and the created sequence is recorded.
Blinding (investigator's opinion)
Double blinded
Blinding description
The primary ultrasound of pregnant women is performed by the research perinatologist to check and determine the length of the cervix. And it is referred to the associate perinatologist for the administration of progesterone and pessary implantation according to the study group. The main researcher examines the final outcome of pregnant women and finally the data analyst performs the data analysis without knowing the type of intervention. It should be noted that the pessary is removed by the main researcher or collaborator of the project during labor pains or gestational age over 37 weeks or cesarean section.
Placebo
Not used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics committee of Iran University of Medical Sciences
Street address
Iran University of Medical Sciences, Shahid Hemmat Highway, Tehran.
City
Tehran
Province
Tehran
Postal code
۱۴۴۹۶۱۴۵۳۵
Approval date
2024-04-27, 1403/02/08
Ethics committee reference number
IR.IUMS.REC.1403.079
Health conditions studied
1
Description of health condition studied
preterm Delivery
ICD-10 code
O94
ICD-10 code description
Sequelae of complication of pregnancy, childbirth, and the puerperium
Primary outcomes
1
Description
The primary outcome of this study is gestational age at delivery time.
Timepoint
gestational age between 16-18
Method of measurement
gestational age(week)
Secondary outcomes
1
Description
Apgar score
Timepoint
After delivery
Method of measurement
apgar score
2
Description
weight
Timepoint
after delivery
Method of measurement
weight
3
Description
NICU addmition
Timepoint
after delivery
Method of measurement
day
4
Description
respiratory distress
Timepoint
after delivery
Method of measurement
respiratory symptoms and chest x ray
5
Description
ICH
Timepoint
after delivery
Method of measurement
brain ultrasonography
Intervention groups
1
Description
Pregnant mothers with twin pregnany who have short cervix length in sonography were included in the study and randomly divided into two groups. In one group only vaginal progesterone suppository and in another group vaginal progesterone suppository and vaginal pessary are inserted and pregnancy outcomes are investigated. Pessary is a device that has different types and is used to treat prolapse in pregnancy or non-pregnancy. And also its types are used for mothers with short cervix length, which usually does not have any complications.
Category
Treatment - Devices
2
Description
Control group: In the control group, pregnant women will be treated with vaginal progesterone (200mg cyclogest/daily) until the end of pregnancy.
Category
Treatment - Drugs
Recruitment centers
1
Recruitment center
Name of recruitment center
Rasoul-e-Akram Hospital
Full name of responsible person
Neda Hashemi
Street address
Rasoul-e-Akram Hospital, Mazar-i-Mansouri St., Sattarkhan Street
City
Tehran
Province
Tehran
Postal code
1445613131
Phone
+98 21 6650 9283
Email
nedahashemi1363@yahoo.com
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Reza Falak
Street address
Hemat Highway next to Milad Tower, Iran University of Medical Sciences
City
تهران
Province
Tehran
Postal code
1449614535
Phone
+98 21 8670 2503
Email
nedahashemi1363@yahoo.com
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Iran University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic
Person responsible for general inquiries
Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Neda Hashemi
Position
Associated professor
Latest degree
Subspecialist
Other areas of specialty/work
Gynecology and Obstetrics
Street address
Rasoul-e-Akram Hospital, Mazar-i-Mansouri St., Sattarkhan Street
City
Tehran
Province
Tehran
Postal code
1445613131
Phone
09821 66509283
Email
nedahashemi1363@yahoo.com
Person responsible for scientific inquiries
Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Neda Hashemi
Position
Associated professor
Latest degree
Subspecialist
Other areas of specialty/work
Gynecology and Obstetrics
Street address
Rasoul-e-Akram Hospital, Mazar-i-Mansouri St., Sattarkhan Street
City
Tehran
Province
Tehran
Postal code
1445613131
Phone
+98 21 6650 9283
Email
nedahashemi1363@yahoo.com
Person responsible for updating data
Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Neda Hashemi
Position
Assistant professor
Latest degree
Subspecialist
Other areas of specialty/work
Gynecology and Obstetrics
Street address
Rasoul-e-Akram Hospital, Mazar-i-Mansouri St., Sattarkhan Street
City
Tehran
Province
Tehran
Postal code
1445613131
Phone
+98 21 6650 9283
Email
nedahashemi1363@yahoo.com
Sharing plan
Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available